BRCA2 and cutaneous melanoma: In cutaneous melanoma, mutations in BRCA1/2 were not statistically different between LOH-high and LOH-low (BRCA1: 1.30% v 1.12%, P = .705; BRCA2: 0.65% v 2.07%, P = .358).